The regulatory landscape for research peptides has tightened
APIs from other sources are subject to detention without physical examination. Read the full Green List Import Alert HERE
This may involve temporarily stopping certain medicines such as ACE inhibitors, ARBs, diuretics, NSAIDs, metformin, or SGLT2 inhibitors until you can drink normally again
Backed by A+ Rated Carriers & underwritten by a team that knows this space inside and out What We Cover Our policies are built to cover: Semaglutide, Tirzepatide, and GLP-1-related protocols BPC-157 and TB-500 for injury and post-op healing Growth hormone peptides (e.g., Ipamorelin, CJC-1295) Melanotan, PT-141, MOTS-c, and thymic peptides Custom or compounded formulations with appropriate medical oversight Optional general liability, property, and equipment protection We Understand the Gray Areas Peptide therapy often lives in the gap between innovation and regulation